News
The Icelandic Medicines Agency starts publishing educational materials on its medicinal product information website
Following a successful pilot project, the Icelandic Medicines Agency has decided to start publishing aRMM educational materials on its website: www.serlyfjaskra.is.
Receipt of clinical trial applications (CTA) summer 2014
Due to summer holiday the Icelandic Medicines Agency (IMA) will not confirm receipt of clinical trial applications (CTA) from 23 June to 11 August 2014.
Fighting availability problems
IMA has informed of and promoted how easy it is to market medicinal and veterinary medicinal products in Iceland, not the least by using multilingual packages.
IMA's Annual Report 2012
IMA's Annual Report 2012 has been published on the website
Rules on reduction of fees collected by IMA
Rules concerning reduction of fees collected in accordance with Tariff 635/2011 have been changed.
Updated - Receipt of clinical trial applications (CTA) summer 2013
Due to summer holiday the Icelandic Medicines Agency (IMA) will not confirm receipt of clinical trial applications (CTA) from 1. July to 16. August 2013.
New guidelines concerning publication of information in the Drug Catalogue and Price list.
A new form has been published.
IMA publishes data about drug consumption in Iceland
The published data contains information about drug consumption in Iceland from 2008-2012.
Revocation of S - classification postponed.
The Icelandic Medicines Agency postpones revocation of S – classification of certain medicinal products.
Rules concerning reduction of fees collected in accordance with Tariff No 635/2011
Rules concerning reduction of fees collected in accordance with Tariff No 635/2011 have been changed, i.e. the implementation of certain parts of the rules is postponed until 1 February 2014.
Specific symbol to label risk communication in Iceland
All Marketing Authorization Holders (MAH) are invited and encouraged to use this symbol